关注
Stéphane PRANGE
Stéphane PRANGE
在 isc.cnrs.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Imaging the etiology of apathy, anxiety, and depression in Parkinson’s disease: implication for treatment
S Thobois, S Prange, V Sgambato-Faure, L Tremblay, E Broussolle
Current neurology and neuroscience reports 17, 1-8, 2017
1162017
Age and time course of long-term motor and nonmotor complications in Parkinson disease
S Prange, T Danaila, C Laurencin, C Caire, E Metereau, H Merle, ...
Neurology 92 (2), e148-e160, 2019
902019
Depression in patients with Parkinson’s disease: current understanding of its neurobiology and implications for treatment
S Prange, H Klinger, C Laurencin, T Danaila, S Thobois
Drugs & Aging 39 (6), 417-439, 2022
812022
Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease
S Prange, E Metereau, A Maillet, E Lhommée, H Klinger, P Pelissier, ...
Movement Disorders 34 (11), 1644-1654, 2019
742019
Serotonergic and dopaminergic lesions underlying parkinsonian neuropsychiatric signs
A Maillet, E Météreau, L Tremblay, E Favre, H Klinger, E Lhommée, ...
Movement Disorders 36 (12), 2888-2900, 2021
482021
What a neurologist should know about PET and SPECT functional imaging for parkinsonism: a practical perspective
S Thobois, S Prange, C Scheiber, E Broussolle
Parkinsonism & related disorders 59, 93-100, 2019
442019
Structural imaging in Parkinson’s disease: new developments
S Prange, E Metereau, S Thobois
Current Neurology and Neuroscience Reports 19, 1-13, 2019
402019
Imaging the limbic system in Parkinson’s disease—a review of limbic pathology and clinical symptoms
M Banwinkler, H Theis, S Prange, T van Eimeren
Brain sciences 12 (9), 1248, 2022
382022
Limbic stimulation drives mania in STN‐DBS in Parkinson disease: a prospective study
S Prange, Z Lin, M Nourredine, T Danaila, C Laurencin, ...
Annals of Neurology 92 (3), 411-417, 2022
172022
Limbic serotonergic plasticity contributes to the compensation of apathy in early Parkinson's disease
S Prange, E Metereau, A Maillet, H Klinger, E Schmitt, E Lhommée, ...
Movement disorders 37 (6), 1211-1221, 2022
162022
Molecular Imaging in Parkinsonian Disorders—What’s New and Hot?
S Prange, H Theis, M Banwinkler, T van Eimeren
Brain Sciences 12 (9), 1146, 2022
142022
Historical crossroads in the conceptual delineation of apathy in Parkinson’s disease
S Prange, J Pagonabarraga, P Krack, J Kulisevsky, V Sgambato, ...
Brain 141 (2), 613-619, 2018
122018
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson’s disease
M Béreau, A Kibleur, M Servant, G Clément, K Dujardin, AS Rolland, ...
Brain 147 (2), 472-485, 2024
72024
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial
C Laurencin, N Timestit, A Marques, DD Duchez, C Giordana, S Meoni, ...
Journal of Neurology 270 (10), 4851-4859, 2023
62023
Noninvasive electrical stimulation for psychiatric care in Down syndrome
J Brunelin, O Adam, E Favre, S Prange, E Zante, C Demily
Brain Stimulation: Basic, Translational, and Clinical Research in …, 2022
62022
Imagerie cérébrale dans les syndromes parkinsoniens
S Prange, M Hermier, T Danaila, C Laurencin, S Thobois
La Presse Médicale 46 (2), 202-209, 2017
52017
Impulsive-compulsive behaviour in early Parkinson’s disease is determined by apathy and dopamine receptor D3 polymorphism
H Theis, S Prange, GN Bischof, MC Hoenig, M Tittgemeyer, ...
npj Parkinson's Disease 9 (1), 154, 2023
42023
Utilisation de l’imagerie cérébrale dans notre pratique face à un syndrome parkinsonien
S Prange, S Thobois
Pratique Neurologique-FMC 11 (2), 135-141, 2020
22020
Amantadine use in the French prospective NS-Park cohort
M Fabbri, V Rousseau, JC Corvol, A Sommet, F Tubach, Y De Rycke, ...
Journal of Neural Transmission, 1-13, 2024
12024
Imaging of impulse control disorders in Parkinson's disease
S Prange, S Thobois
Revue Neurologique, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20